Yu-Feng Yang

548 total citations
16 papers, 356 citations indexed

About

Yu-Feng Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu-Feng Yang has authored 16 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Yu-Feng Yang's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yu-Feng Yang is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yu-Feng Yang collaborates with scholars based in China and Czechia. Yu-Feng Yang's co-authors include Meifang Zhang, Qiu‐Hong Tian, Chris Zhiyi Zhang, Jia Fu, Yang Xia, Yinghua Pan, Xuhui Liu, Hong Yang, Shu‐Guang Su and Wei Chen and has published in prestigious journals such as Journal of Cell Science, Molecular Cancer and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Yu-Feng Yang

16 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu-Feng Yang China	9	283	137	57	51	51	16	356
Qiu‐Hong Tian China	9	327 1.2×	138 1.0×	76 1.3×	58 1.1×	48 0.9×	18	419
Walter Wai Yeung China	7	222 0.8×	139 1.0×	55 1.0×	70 1.4×	27 0.5×	8	335
Luxi Qian China	13	317 1.1×	258 1.9×	41 0.7×	62 1.2×	30 0.6×	25	423
Xudong Chen China	12	222 0.8×	203 1.5×	42 0.7×	79 1.5×	63 1.2×	21	348
Ziling Fang China	15	404 1.4×	184 1.3×	45 0.8×	129 2.5×	71 1.4×	25	493
Shinya Kidogami Japan	12	236 0.8×	114 0.8×	49 0.9×	66 1.3×	24 0.5×	26	321
Shenglan Huang China	11	150 0.5×	95 0.7×	66 1.2×	69 1.4×	48 0.9×	23	295
Qinghua Xi China	10	221 0.8×	77 0.6×	31 0.5×	94 1.8×	35 0.7×	17	289
Heping Kan China	12	290 1.0×	221 1.6×	72 1.3×	89 1.7×	32 0.6×	18	425

Countries citing papers authored by Yu-Feng Yang

Since Specialization

Citations

This map shows the geographic impact of Yu-Feng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Feng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Feng Yang more than expected).

Fields of papers citing papers by Yu-Feng Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Feng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Feng Yang. The network helps show where Yu-Feng Yang may publish in the future.

Co-authorship network of co-authors of Yu-Feng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Feng Yang. A scholar is included among the top collaborators of Yu-Feng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Feng Yang. Yu-Feng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Sun, Yangyang, Weidong Li, Yang Chen, et al.. (2025). Activation of the cGAS-STING pathway in monocytes exacerbates pulmonary fibrosis induced by paraquat poisoning. Toxicology and Applied Pharmacology. 504. 117502–117502. 2 indexed citations

Ye, Jinjun, Haohai Huang, Dan Liao, et al.. (2024). METTL3-driven m6A modification of lncRNA FAM230B suppresses ferroptosis by modulating miR-27a-5p/BTF3 axis in gastric cancer. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(11). 130714–130714. 1 indexed citations

Yang, Mei, et al.. (2024). TAF15 inhibits p53 nucleus translocation and promotes HCC cell 5-FU resistance via post-transcriptional regulation of UBE2N. Journal of Physiology and Biochemistry. 80(4). 919–933. 1 indexed citations

Ye, Jinjun, et al.. (2021). Combined targeting of vascular endothelial growth factor C (VEGFC) and P65 using miR-27b-3p agomir and lipoteichoic acid in the treatment of gastric cancer. Journal of Gastrointestinal Oncology. 12(1). 121–132. 6 indexed citations

Ye, Jinjun, et al.. (2021). circRNA_0006470 promotes the proliferation and migration of gastric cancer cells by functioning as a sponge of miR-27b-3p. Neoplasma. 68(6). 1245–1256. 14 indexed citations

Pu, Rong, et al.. (2020). LncRNA FAM230B Promotes Gastric Cancer Growth and Metastasis by Regulating the miR-27a-5p/TOP2A Axis. Digestive Diseases and Sciences. 66(8). 2637–2650. 39 indexed citations

Zhang, Meifang, Qiuli Li, Yu-Feng Yang, Yun Cao, & Chris Zhiyi Zhang. (2020). FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 10. 564614–564614. 8 indexed citations

Yang, Yu-Feng, Meifang Zhang, Qiu‐Hong Tian, et al.. (2018). SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Molecular Cancer. 17(1). 117–117. 65 indexed citations

Yang, Yu-Feng, et al.. (2018). CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma. Translational Oncology. 11(5). 1110–1118. 33 indexed citations

10.

Liu, Xuhui, et al.. (2017). CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology. 90. 1–8. 19 indexed citations

11.

Lin, Mei‐Fang, Yu-Feng Yang, Zhenpeng Peng, et al.. (2017). FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma. The International Journal of Biochemistry & Cell Biology. 88. 155–161. 55 indexed citations

12.

Yang, Yu-Feng, Meifang Zhang, Qiu‐Hong Tian, & Chris Zhiyi Zhang. (2017). TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma. Journal of Cell Science. 130(18). 3108–3115. 56 indexed citations

13.

Yang, Yu-Feng, Yinghua Pan, Yun Cao, et al.. (2017). PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma. Oncotarget. 8(29). 47195–47205. 32 indexed citations

14.

Liu, Rongfu, et al.. (2015). Pygopus 2 promotes kidney cancer OS-RC-2 cells proliferation and invasion in vitro and in vivo. Asian journal of urology. 2(3). 151–157. 8 indexed citations

15.

Yang, Yu-Feng, et al.. (2014). Prognostic Role of Nucleophosmin in Colorectal Carcinomas. Asian Pacific Journal of Cancer Prevention. 15(5). 2021–2026. 15 indexed citations

16.

Yang, Yu-Feng, et al.. (2010). [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].. PubMed. 32(10). 795–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact